1. Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses;Ungerechts;Mol. Ther. Methods Clin. Dev.,2016
2. Into the clinic: talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy;Rehman;J. ImmunoTher. Cancer,2016
3. SillaJen Inc., Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone, in, 〈https://ClinicalTrials.gov/show/NCT02562755〉.
4. Oncolytic viruses in cancer treatment: a review;Lawler;JAMA Oncol.,2016
5. U.S. Food, Drug Administration Guidance for Industry, Sterile Drug Products Produced by Aseptic Processing–Current Good Manufacturing Practice, Rockville, MD, 2004.